DELIVERING RESULTS FOR YOUR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS

DELIVERING RESULTS FOR YOUR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS

Icon: Checkmark

CHOOSE BENLYSTA FOR YOUR APPROPRIATE
PATIENTS

BENLYSTA: EFFICACY IN PATIENTS WITH SLE1-3

Icon: Disease Activity

Disease activity

Primary endpoint

Icon: Severe Flare

Risk of severe flare

Secondary endpoint

Icon: Steroid Dose

Steroid dose

Secondary endpoint

BENLYSTA: EFFICACY IN PATIENTS WITH LUPUS NEPHRITIS4

Icon: Kidneys

Renal response

Icon: Renal Related Events

Renal-related events

Icon: BENLYSTA Efficacy

Established Efficacy in SLE

BENLYSTA has demonstrated efficacy across a variety of patient types.

Learn More

Icon: Real World Evidence

Real-World Evidence

Find out about BENLYSTA and organ damage accrual in the real-world setting.

Learn More

Icon: BENLYSTA Dosing Options

Dosing Flexibility

BENLYSTA is available in multiple formulations for adult patients. Talk to your patients about which formulation is right for them.

Learn More

Icon: Silhouette

Safety

BENLYSTA has a safety profile observed in 8 clinical trials.

Learn More

Who is your Benlysta patient?

SLE

42 years old

Diagnosed with SLE 6 years ago

Meet Lindsay

SLE

42 years old

Diagnosed with SLE 2 years ago

Meet Laura

Lupus Nephritis

34 years old

Diagnosed with LN 4 years ago

Meet Ashley

Pediatric SLE

12 years old

Diagnosed with SLE 3 years ago

Meet Sophia

Now’s the time to treat lupus and lupus nephritis with BENLYSTA

Now’s the
time to treat lupus and
lupus nephritis with BENLYSTA